Literature DB >> 15804393

High prevalence of personality disorders among healthy volunteers for research: implications for control group bias.

Scott C Bunce1, Kurtis L Noblett, Michael S McCloskey, Emil F Coccaro.   

Abstract

Individuals who volunteer as control subjects for clinical studies are regularly screened for Axis I diagnoses, but seldom screened for Axis II disorders. This study examined the relative rates of Axis II diagnoses among 341 volunteers passing an initial telephone screen for entry into biological research studies. Axis I and II diagnoses by DSM-IV were assigned by best estimate after structured clinical interview, and subjects were categorized into one of three groups based on their diagnostic profiles: (1) volunteers without lifetime Axis I or II diagnoses ("healthy controls"), (2) personality-disordered volunteers without any history of Axis I pathology, and (3) personality-disordered volunteers with past (but not current) Axis I pathology. The results revealed a high prevalence of personality disorders (44.4%) among these volunteers. Several clinically relevant self-report inventories were used to demonstrate important characterological differences between the three comparison groups. Although inventory results demonstrated multiple differences between all three groups, most scales revealed differences between healthy controls and the two personality-disordered groups (with or without lifetime Axis I diagnoses), suggesting that most of the variance was accounted for by the presence or absence of an Axis II disorder, not a past Axis I disorder. These results suggest that personality-disordered volunteers may bias a control group due to the infrequent screening for Axis II disorders among volunteers for medical and psychiatric research. Implications are discussed for routine Axis II screening of volunteers for research with specific diagnostic instruments.

Entities:  

Mesh:

Year:  2004        PMID: 15804393     DOI: 10.1016/j.jpsychires.2004.09.005

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  10 in total

1.  Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects.

Authors:  Emil F Coccaro; Royce Lee; Paul Vezina
Journal:  J Psychiatr Res       Date:  2013-06-18       Impact factor: 4.791

2.  Safety, Science, or Both? Deceptive Healthy Volunteers: Psychiatric Conditions Uncovered by Objective Methods of Screening.

Authors:  Adriana Pavletic; Maryland Pao
Journal:  Psychosomatics       Date:  2017-05-09       Impact factor: 2.386

3.  Lifetime history of cigarette smoking associated with aggression and impulsivity in both healthy and personality disordered volunteers.

Authors:  Elias Dakwar; Marias Popii; Emil F Coccaro
Journal:  J Pers Disord       Date:  2011-10

4.  Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.

Authors:  Emil F Coccaro; Royce Lee; Richard J Kavoussi
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study.

Authors:  Emil F Coccaro; Royce Lee; Mary Coussons-Read
Journal:  J Neural Transm (Vienna)       Date:  2014-07-24       Impact factor: 3.575

6.  Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects.

Authors:  Emil F Coccaro; Royce Lee
Journal:  J Neural Transm (Vienna)       Date:  2010-02       Impact factor: 3.575

7.  Cannabis withdrawal in the United States: results from NESARC.

Authors:  Deborah S Hasin; Katherine M Keyes; Donald Alderson; Shuang Wang; Efrat Aharonovich; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2008-09-09       Impact factor: 4.384

8.  Potential Mood Variation Following a Behavioral Analogue of Self-Injurious Behavior.

Authors:  Brooke A Ammerman; Kristen M Sorgi; Mitchell E Berman; Emil F Coccaro; Michael S McCloskey
Journal:  Arch Suicide Res       Date:  2018-11-22

9.  CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication.

Authors:  Linda Kaerlev; Maria Iachina; Jesper Holst Pedersen; Anders Green; Bente Mertz Nørgård
Journal:  BMC Cancer       Date:  2012-05-23       Impact factor: 4.430

10.  Cerebrospinal fluid inflammatory cytokines and aggression in personality disordered subjects.

Authors:  Emil F Coccaro; Royce Lee; Mary Coussons-Read
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-03       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.